Ownership Summary
A total of 1 institutions have reported a stake in BioNexus Gene Lab Corp (NASDAQ:BGLC) as of December 2025, according to recent 13F filings with the SEC.
- These investors collectively held 2.7% of the company's total shares outstanding in December 2025, up from 1.2% in September 2025.
- The company experienced a 226.46% quarterly change in institutional shares held, alongside a decrease of 85.71% in total owners annually.
- The latest 13F cycle for BioNexus Gene Lab reveals that of 1 total investors, 1 funds grew their exposure, whereas 0 reduced theirs and 0 made no changes.
- The aggregate institutional position in BioNexus Gene Lab now stands at 47.83K shares as of December 2025, after investors increased their holdings (up by 33.18K shares quarter on quarter which is down 130.27K shares year over year).
- DRW Securities, LLC continues to be the largest institutional holder of BioNexus Gene Lab as of December 31, 2025, with a position of 47.83K shares, representing 2.66% of the company's outstanding stock.
- Among the most significant buyers of BioNexus Gene Lab during December 2025 were DRW Securities, LLC (33.18K).
- The top 1 institutional holders of BioNexus Gene Lab for the quarter ending December 2025 included DRW Securities, LLC (47.83K).